Evidence map›Paper›PMID 30364987›Full record

ArticleNucleic acids research2018

Human MARF1 is an endoribonuclease that interacts with the DCP1:2 decapping complex and degrades target mRNAs.

Tamiko Nishimura, Hana Fakim, Tobias Brandmann, Ji-Young Youn, Anne-Claude Gingras, Martin Jinek, Marc R Fabian

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Molecular Markers of Ovarian Germ Cells of Banana Prawn (Current issues in molecular biology · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Molecular mimicry between SARS-CoV-2 and the female reproductive system.American journal of reproductive immunology (New York, N.Y. : 1989) · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Tamiko NishimuraLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Hana FakimLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Tobias BrandmannDepartment of Biochemistry, University of Zurich, Switzerland.
Ji-Young YounLunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
Anne-Claude GingrasLunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
Martin JinekDepartment of Biochemistry, University of Zurich, Switzerland.
Marc R FabianLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Jewish General Hospital · CAUniversity of Zurich · CHLunenfeld-Tanenbaum Research Institute · CAUniversity of Toronto · CA

Funding

CIHR MOP-130425
6 · The paper itself

Abstract

Meiosis arrest female 1 (MARF1) is a cytoplasmic RNA binding protein that is essential for meiotic progression of mouse oocytes, in part by limiting retrotransposon expression. MARF1 is also expressed in somatic cells and tissues; however, its mechanism of action has yet to be investigated. Human MARF1 contains a NYN-like domain, two RRMs and eight LOTUS domains. Here we provide evidence that MARF1 post-transcriptionally silences targeted mRNAs. MARF1 physically interacts with the DCP1:DCP2 mRNA decapping complex but not with deadenylation machineries. Importantly, we provide a 1.7 Å resolution crystal structure of the human MARF1 NYN domain, which we demonstrate is a bona fide endoribonuclease, the activity of which is essential for the repression of MARF1-targeted mRNAs. Thus, MARF1 post-transcriptionally represses gene expression by serving as both an endoribonuclease and as a platform that recruits the DCP1:DCP2 decapping complex to targeted mRNAs.

Indexed as

RNA InterferenceAmino Acid SequenceAnimalsBinding SitesCell Cycle ProteinsCrystallography, X-RayEndoribonucleasesEscherichia coliGene ExpressionHEK293 CellsHeLa CellsHumansMiceModels, MolecularProtein BindingProtein Conformation, alpha-HelicalCell Cycle ProteinsDCP1A protein, humanDCP2 protein, humanEndoribonucleasesMARF1 protein, humanMARF1 protein, mouseProtein IsoformsRecombinant ProteinsRNA, MessengerTrans-Activators

Identifiers

PMID30364987
PMCPMC6294520
OpenAlexW2898159486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.